Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Akylox Therapeutics ApS
APS
Active
Reklamebeskyttelse
CVR 44974045
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Akylox Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-1M
-2M
-2M
-2M
2025
EBITDA
DKK millions
0M
-6M
-12M
-18M
-24M
-19M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-2.369
Staff expenses
-1.221
EBITDA
-18.502
Depreciation & amort.
-0
EBIT
-18.502
Net financials
-5.862
Profit before tax
-24.364
Tax
-3.345
Net profit
-21.019
Balance sheet
DKK thousands
Item
2025
Total assets
14.529
Equity
11.292
Long-term debt
0
Short-term debt
3.236
Total debt
3.236
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-1850170700.0%
This company
2025
2025
Soliditetsgrad
77.7%
This company
38.2%
Market median
+103% vs market
2025
2025
Egenkapitalforrentning
-186.1%
This company
18.4%
Market median
-1111% vs market
2025
2025
Nettoresultatgrad (af bruttofortjeneste)
-2101905500.0%
This company
2025
2025
Aktivomsætning (af bruttofortjeneste)
-0.16×
This company
2025
2025
Gæld/egenkapital
0.29×
This company
0.62×
Market median
+53% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-05 – 2025-12-31
View
PDF
More on Akylox Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
